Adagio Therapeutics

AMAG Pharmaceuticals is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. The company has two commercial products, Feridex I.V. and GastroMARK, both of which are imaging agents that are approved and marketed in the United States, Europe and other countries. Ferumoxytol, the company's key product candidate, is being developed for use as an intravenous iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease. Combidex, the company's other product under development, is an investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with magnetic resonance imaging (MRI) to aid in the differentiation of cancerous from normal lymph nodes. AMAG Pharmaceuticals corporate and executive offices are located in Cambridge, Mass.

TScan Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, focused on developing innovative T cell therapies aimed at transforming the lives of cancer patients. By harnessing the power of the human immune system, TScan is dedicated to discovering new cancer targets and creating safe, effective treatment options. The company's therapeutic approach centers on learning from patients who are successfully battling cancer to inform treatments for those facing more challenging diagnoses. With a robust pipeline and commitment to patient care, TScan Therapeutics is poised to make significant contributions to the field of cancer therapy. Generated from the website

PerkinElmer is a provider of scientific instruments, consumables and services to the pharmaceutical, biomedical, environmental testing and general industrial markets. The company designs, manufactures, markets and services products for the fields of life and analytical sciences, optoelectronics and fluid sciences. The company s life and analytical sciences division provides drug discovery, genetic screening, environmental and chemical analysis tools and instrumentation. Its optoelectronics division provides technology for biomedical imaging and industrial smart devices. The company s fluid sciences division works with aerospace, semiconductor processing and energy technology companies. PerkinElmer employs more than 8,000 people and serves customers in more than 125 countries. The company is headquartered in Wellesley, Mass.